These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30777646)

  • 21. First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland.
    Uosukainen H; Bell JS; Laitinen K; Tacke U; Ilomäki J; Turunen JH
    Int J Drug Policy; 2013 Sep; 24(5):492-7. PubMed ID: 23567099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
    Lawrinson P; Roche A; Terao H; Le PP
    Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
    Green TC; Case P; Fiske H; Baird J; Cabral S; Burstein D; Schwartz V; Potter N; Walley AY; Bratberg J
    J Am Pharm Assoc (2003); 2017; 57(2S):S19-S27.e4. PubMed ID: 28214219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-perceived problem with alcohol use among opioid substitution treatment clients.
    Islam MM; Day CA; Conigrave KM; Topp L
    Addict Behav; 2013 Apr; 38(4):2018-21. PubMed ID: 23384455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes.
    Lee EL; Wong PS; Tan MY; Sheridan J
    Int J Pharm Pract; 2018 Apr; 26(2):138-147. PubMed ID: 28574154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consumers' perceptions of community pharmacy in Portugal: a qualitative exploratory study.
    Cavaco AM; Dias JP; Bates IP
    Pharm World Sci; 2005 Feb; 27(1):54-60. PubMed ID: 15861936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives of pharmacy staff on dispensing subtherapeutic doses of antibiotics: a theory informed qualitative study.
    Amin MEK; Amine A; Newegy MS
    Int J Clin Pharm; 2017 Oct; 39(5):1110-1118. PubMed ID: 28714040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Making the invisible visible' through alcohol screening and brief intervention in community pharmacies: an Australian feasibility study.
    Hattingh HL; Hallett J; Tait RJ
    BMC Public Health; 2016 Nov; 16(1):1141. PubMed ID: 27825369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A qualitative exploration of opinions on the community pharmacists' role amongst the general public in Scotland.
    Gidman W; Cowley J
    Int J Pharm Pract; 2013 Oct; 21(5):288-96. PubMed ID: 23418884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Societal perspectives on community pharmacy services in West Bank - Palestine.
    Khdour MR; Hallak HO
    Pharm Pract (Granada); 2012 Jan; 10(1):17-24. PubMed ID: 24155812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.
    Radley A; Tait J; Dillon JF
    Int J Drug Policy; 2017 Sep; 47():126-136. PubMed ID: 28647161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How does the public conceptualise the quality of care and its measurement in community pharmacies in the UK: a qualitative interview study.
    Watson MC; Silver K; Watkins R
    BMJ Open; 2019 Mar; 9(3):e027198. PubMed ID: 30928961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.
    Deering DEA; Sheridan J; Sellman JD; Adamson SJ; Pooley S; Robertson R; Henderson C
    Addict Behav; 2011 Jun; 36(6):636-642. PubMed ID: 21276664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumers' expectations and experiences with chain community pharmacies in Lahore, Pakistan: a qualitative exploratory study.
    Asif U; Saleem A; Masood I; Nawaz M
    Int J Clin Pharm; 2019 Jun; 41(3):813-819. PubMed ID: 31028597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing clients' knowledge of community pharmacists' roles.
    Chewning B; Schommer JC
    Pharm Res; 1996 Sep; 13(9):1299-304. PubMed ID: 8893265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.